Arrowhead Pharma (ARWR) Stock Up 481% in a Year — Analysts Say There’s More to Come
CoinCentral·60-word summary·1 min read
Arrowhead Pharma (ARWR) stock has surged 481% over the past year, with analysts predicting further gains. Morgan Stanley upgraded ARWR to Overweight with a $100 price target, citing upcoming Phase 3 data for the drug plozasiran, expected in Q3 2026. BofA also raised its price target, estimating a peak market of around $3 billion for the drug.
New York Attorney General Letitia James has accused Coinbase and Gemini of operating unlicensed prediction markets, intensifying regulatory scrutiny on crypto firms. The crackdown, announced on April 21, 2026, aims to address concerns over unregulated event-based trading platforms, reflecting broader efforts by New York to tighten oversight of the crypto industry. The move signals increased regulatory pressure on major exchanges.
Cardano (ADA) is trading at $0.25, with potential to reclaim $0.30 as CME futures volumes surge. The recent price rise aligns with increased futures activity over the past three days, indicating growing investor interest. Analysts suggest that rising futures volumes could support further price recovery for ADA in the coming weeks.
Kalshi is planning to expand into crypto markets by offering perpetual futures trading, according to reports. Currently, Coinbase and Binance provide prediction markets, reflecting growing interest in event outcome wagering. The move signals increased integration of traditional prediction platforms with crypto trading, as the industry seeks to diversify offerings and attract more users. No specific launch date or financial figures were disclosed.
Crypto analyst Trader Tardigrade predicts Dogecoin could rally 3,000% to $4, driven by a bullish setup and an inverse head and shoulders pattern. The analyst highlights fading selling pressure and bullish divergence signals, suggesting a potential trend reversal. If confirmed, this move could mirror the 2017 rally, where DOGE surged from $0.00017 to $0.005.
Palantir (PLTR) stock, down 18% year-to-date, received a boost after Trump praised its “war fighting capabilities,” but Wall Street remains skeptical due to high valuation concerns. The company reported Q4 earnings of $0.25 EPS on $1.41 billion revenue, a 70% increase year-over-year. Despite strong earnings, PLTR trades at a P/E ratio over 231, with a 200-day moving average of $164.55.
Seagate Technology (STX) reached an all-time high of $554.21, with a 1-year return of 639.49%, and a market cap of $123.3 billion. The company's revenue grew 25%, and BofA projects Q3 FY2026 revenue of $3.02 billion and EPS of $3.70, surpassing analyst estimates. Seagate also announced the sale of its Lyve Cloud storage business to Wasabi.